NCT07259213
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07259213
Title A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC (RAD402)
Acronym RAD402
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Radiopharm Theranostics, Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.